Results 11 to 20 of about 19,557 (198)
The Usage of Concomitant Beta-Blockers with Vasopressors and Inotropes in Cardiogenic Shock
Medical Sciences (Basel, Switzerland), 2022 Vasopressors and inotropes (Vs/Is) are widely used in the treatment of cardiogenic shock (CS). Despite improvements in hemodynamic variables and end-organ perfusion, these agents have been associated with an increase in mortality, potentially due to the ...
Rachel Ryu
exaly +3 more sources
Outcomes of Use of Inotropes at Waitlisting Through Heart Transplantation: The UNOS Experience [PDF]
Journal of Cardiovascular Development and DiseaseBackground: Despite its use in patients awaiting heart transplant (HT), the impact of continuous inotropic support on short-term complications and long-term transplant outcomes remains unclear.
Marco Gemelli +12 more
doaj +2 more sources
Vasopressors and inotropes in cardiogenic shock patients: an analysis of the MIMIC-IV database
Frontiers in Cardiovascular Medicine, 2023 IntroductionPharmacological support has become the mainstay therapy in patients with cardiogenic shock (CS). Unfortunately, the clinical benefits of such potent drugs remain unclear, therefore, the present study aims to elucidate the safety and efficacy ...
Siyuan Xie
exaly +3 more sources
Advanced heart failure: state of the art and future directions [PDF]
Reviews in Cardiovascular Medicine, 2022 Advanced heart failure is a clinical challenge that requires a pathophysiological-based approach. As the field has been the subject of multiple reviews, the objective of this paper is not to duplicate these publications but rather to offer practical ...
Daniele Masarone +3 more
doaj +1 more source
Role of Arterial Serum Lactate as a Predictor of Undifferentiated Shock on Admission and its Outcome- A Cohort Study [PDF]
Journal of Clinical and Diagnostic Research, 2021 Introduction: Patients with elevated serum lactate levels may be at risk for considerable morbidity and mortality and require a prompt, thoughtful and systematic approach for diagnosis and treatment.
Avadhesh Kumar Sharma +4 more
doaj +1 more source
Dobutamine-Induced Myoclonus in a Peritoneal Dialysis Patient: Case Report
Kidney Medicine, 2023 Dobutamine is a weak beta-1 and a potent beta-2 adrenergic agonist commonly used to treat patients in cardiogenic shock. It enhances myocardial contractibility, increasing cardiac output.
Edva Noel +5 more
doaj +1 more source
Diuretic resistance in patients with chronic heart failure: mechanisms, prevention, and treatment
Бюллетень сибирской медицины, 2022 The authors analyzed the problem of diuretic resistance (DR) in patients with chronic heart failure (CHF). Most of the symptoms and signs of CHF are associated with hypervolemia and vascular congestion in the systemic and pulmonary circulation.
V. V. Kalyuzhin +11 more
doaj +1 more source
Cardiogenic shock - novelty and emerging therapeutic concepts [PDF]
Българска кардиология, 2022 The cardiogenic shock is a state of low cardiac output, primarily due to cardiac dysfunction, which leads to severe organ hypoperfusion with tissue hypoxia and increased lactate levels. It presents a severe complication with a prevalence of around 15% of
I. Petrov, Z. Stankov, S. Vasilev
doaj +3 more sources
Case Reports in Orthopedic Research, 2023 Symmetrical peripheral gangrene (SPG) is a rare condition. At present, there is no clear etiology for this condition; however, it has been associated with multiple risk factors, including sepsis and coagulopathy.
Yahya Alborno +5 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 BackgroundMany patients with advanced heart failure (HF) are administered chronic intravenous inotropic support (CIIS) as bridge to surgical therapy; some ultimately never receive surgery.
Anirudh Rao +12 more
doaj +1 more source